Evelo Biosciences, Inc. EVLO OTC

Other OTC • Healthcare • Biotechnology • US • USD

Il y a eu 50 transactions d'initiés récentes enregistrées pour Evelo Biosciences, Inc. (EVLO), dont 24 achats et 24 ventes. Le total des achats d'initiés s'élève à $3.5M et le total des ventes d'initiés à $126.54K.

Les initiés notables ayant une activité récente comprennent Gill Simba, Bodmer Mark, Mchale Duncan. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — EVLO

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2023-11-08	Gill Simba	President & CEO	Vente Informative	172	$0.33	$56.76	17,758
2023-11-08	Bodmer Mark	CSO, President of R&d	Vente Informative	3,163	$0.33	$1.04K	25,732
2023-11-08	Mchale Duncan	Chief Medical Officer	Vente Informative	3,103	$0.33	$1.02K	16,984
2023-11-08	Thorell Marella	Chief Financial Officer	Vente Informative	1,811	$0.33	$597.63	22,259
2023-11-07	Gill Simba	President & CEO	Exercice d'Options (Vente)	1,172	-	-	15,236
2023-11-07	Bodmer Mark	CSO, President of R&d	Exercice d'Options (Vente)	6,625	-	-	6,625
2023-11-07	Mchale Duncan	Chief Medical Officer	Exercice d'Options (Vente)	6,500	-	-	6,500
2023-11-07	Thorell Marella	Chief Financial Officer	Exercice d'Options (Vente)	6,500	-	-	6,500
2023-11-02	Bodmer Mark	CSO, President of R&d	Vente Informative	6,854	$0.33	$2.26K	22,270
2023-11-02	Mchale Duncan	Chief Medical Officer	Vente Informative	6,854	$0.33	$2.26K	13,587
2023-11-02	Thorell Marella	Chief Financial Officer	Vente Informative	3,999	$0.33	$1.32K	17,570
2023-11-01	Bodmer Mark	CSO, President of R&d	Exercice d'Options (Vente)	12,500	-	-	25,000
2023-11-01	Mchale Duncan	Chief Medical Officer	Exercice d'Options	12,500	-	-	20,441
2023-11-01	Thorell Marella	Chief Financial Officer	Exercice d'Options	12,500	-	-	21,569
2023-09-28	Gill Simba	President & CEO	Vente Informative	1,996	$3.94	$7.86K	16,758
2023-09-27	Gill Simba	President & CEO	Exercice d'Options	15,000	-	-	18,754
2023-09-11	Bodmer Mark	CSO, President of R&d	Attribution de RSU	37,500	-	-	37,500
2023-09-11	Mchale Duncan	Chief Medical Officer	Attribution de RSU	37,500	-	-	37,500
2023-09-11	Thorell Marella	Chief Financial Officer	Attribution de RSU	37,500	-	-	37,500
2023-08-08	Gill Simba	President & CEO	Vente Informative	342	$9.51	$3.25K	3,754
2023-08-08	Bodmer Mark	CSO, President of R&d	Vente Informative	3,128	$9.51	$29.75K	16,624
2023-08-08	Mchale Duncan	Chief Medical Officer	Vente Informative	3,434	$9.51	$32.66K	7,941
2023-08-08	Thorell Marella	Chief Financial Officer	Vente Informative	2,004	$9.51	$19.06K	9,069
2023-08-07	Gill Simba	President & CEO	Exercice d'Options	1,171	-	-	4,096
2023-08-07	Bodmer Mark	CSO, President of R&d	Exercice d'Options (Vente)	6,625	-	-	13,250
2023-08-07	Mchale Duncan	Chief Medical Officer	Exercice d'Options	6,500	-	-	11,375
2023-08-07	Thorell Marella	Chief Financial Officer	Exercice d'Options	6,500	-	-	11,073
2023-07-11	Moore Jeffrey R.	Director	Inconnu	-	-	-	-
2023-07-11	Moore Jeffrey R.	Director	Attribution de RSU	2,000	$3.38	$6.76K	2,000
2023-07-11	Reynolds Alexander C	Director	Inconnu	-	-	-	-
2023-07-11	Reynolds Alexander C	Director	Attribution de RSU	2,000	$3.38	$6.76K	2,000
2023-07-11	Flagship Ventures Fund Iv General Partner Llc	10 Percent Owner	Achat Informatif	1,082,251	$2.31	$2.5M	1,461,795
2023-07-11	Horizon Technology Finance Corp	10 Percent Owner	Cession	-	-	-	2,164,502
2023-06-08	Gill Simba	President & CEO	Attribution de RSU	1,000,000	$0.97	$970K	1,000,000
2023-06-08	Melas Kyriazi Theo	Director	Attribution de RSU	20,000	$0.11	$2.2K	20,000
2023-06-08	Mchugh Julie	Director	Attribution de RSU	20,000	$0.11	$2.2K	20,000
2023-06-08	Rosiello Robert L.	Director	Attribution de RSU	30,000	$0.11	$3.3K	30,000
2023-06-08	Gutierrez-ramos Jose-carlos	Director	Attribution de RSU	20,000	$0.11	$2.2K	20,000
2023-06-08	Hohneker John	Director	Attribution de RSU	20,000	$0.11	$2.2K	20,000
2023-06-08	Andres Juan	Director	Attribution de RSU	20,000	$0.11	$2.2K	20,000
2023-06-08	Mcinnes Iain B.	Director	Attribution de RSU	20,000	$0.11	$2.2K	20,000
2023-06-08	Williams Tonya	Director	Attribution de RSU	20,000	$0.11	$2.2K	20,000
2023-05-23	Bodmer Mark	CSO, President of R&d	Vente Informative	22,571	$0.14	$3.2K	262,557
2023-05-08	Gill Simba	President & CEO	Vente Informative	3,537	$0.13	$443.89	58,512
2023-05-08	Bodmer Mark	CSO, President of R&d	Vente Informative	68,014	$0.13	$8.54K	285,128
2023-05-08	Mchale Duncan	Chief Medical Officer	Vente Informative	66,730	$0.13	$8.37K	97,516
2023-05-08	Thorell Marella	Chief Financial Officer	Vente Informative	38,531	$0.13	$4.84K	91,469
2023-05-07	Gill Simba	President & CEO	Exercice d'Options	23,437	-	-	62,049
2023-05-07	Bodmer Mark	CSO, President of R&d	Exercice d'Options	132,500	-	-	353,142
2023-05-07	Mchale Duncan	Chief Medical Officer	Exercice d'Options	130,000	-	-	164,246

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration